Company: KROS
Filing Date: 2025-04-10
Form Type: 8-K
Source: 0001664710-25-000033
Chunk: 6

Company: Keros Therapeutics, Inc.
Filing Date: 2025-04-10
Form: 8-K
Item: Item 5.03
Chunk 6
---
Item 5.03 Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year.

In connection with the adoption of the Rights Agreement referenced in Item 1.01 above, the Board approved the Certificate of Designations establishing the Preferred Shares and the rights, preferences and privileges thereof. The Certificate of Designations was filed with the Secretary of State of the State of Delaware on April 9, 2025. The Certificate of Designations is attached hereto as Exhibit 3.1 and is incorporated herein by reference. The information set forth under Item 1.01 above is incorporated herein by reference.

Item 8.01 Other Events.